Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular Effects

Autor: Edmund Lee, Michelle A. Lowes, Judilyn Fuentes-Duculan, Frank Wang, Irma Cardinale, Asifa Haider, Francesca Chamian, James G. Krueger, Maria Veronica Abello
Rok vydání: 2006
Předmět:
Adult
Keratinocytes
Integrin beta Chains
Recombinant Fusion Proteins
medicine.medical_treatment
CD2 Antigens
Antigens
Differentiation
Myelomonocytic

Alefacept
Inflammation
Dermatology
Biology
Biochemistry
Monocytes
Interferon-gamma
030207 dermatology & venereal diseases
03 medical and health sciences
0302 clinical medicine
Interleukin 20
Downregulation and upregulation
Antigens
CD

Psoriasis
Leukocytes
medicine
Humans
RNA
Messenger

Receptor
Molecular Biology
Oligonucleotide Array Sequence Analysis
Skin
030304 developmental biology
0303 health sciences
Tumor Necrosis Factor-alpha
Interleukins
Receptors
Interleukin

Cell Biology
medicine.disease
CD11c Antigen
medicine.anatomical_structure
Cytokine
Gene Expression Regulation
Immunology
Cancer research
Tumor necrosis factor alpha
medicine.symptom
Keratinocyte
Zdroj: Journal of Investigative Dermatology. 126(7):1590-1599
ISSN: 0022-202X
DOI: 10.1038/sj.jid.5700310
Popis: We assessed expression of IL-20 and its receptors in psoriasis, given the recent implication of IL-20 in epidermal hyperplasia. Psoriatic lesional (LS) skin consistently expressed more IL-20 mRNA than nonlesional (NL) skin. Immunoreactivity to IL-20 protein was greater in LS tissue and mainly localized to infiltrating CD68 + /CD11c + (myeloid-derived) dermal leukocytes. Because this contrasted with earlier reports of a keratinocyte source, we assessed IL-20 mRNA expression in a variety of cells in vitro , and confirmed a myeloid-derived cellular source (monocytes). Plastic adhesion, activation of β 2 integrins, and incubation with tumor necrosis factor- α stimulated expression in these cells. IL-20 receptor (IL-20R) α and IL-20R β mRNA was decreased in LS versus NL skin, which also contrasted with earlier findings. To investigate the relationship between IL-20 and disease activity, we examined psoriasis patients treated with the CD2-targeted agent alefacept. In therapeutic responders, lesional IL-20 mRNA decreased to NL levels, suggesting that CD2 + leukocytes may proximally regulate IL-20. Finally, to assess IL-20 function, we used microarrays to screen IL-20-treated keratinocytes, which demonstrated upregulation of disease-related and IFN- γ -induced genes. Hence, IL-20 may influence inflammation through IFN-like effects. Together, these data indicate that IL-20 may be an important effector cytokine in psoriasis, and that its inhibition may represent a potential therapeutic target.
Databáze: OpenAIRE